INDOCO REMEDIES LTD.
BSE: 532612
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|---|---|---|
| INCOME | |||||||
| Revenue | 449.13+12.1% | 400.51-9.4% | 442.12+12.6% | 392.53+13.0% | 347.25-6.9% | 372.98-5.9% | 396.53 |
| Other Income | 10.35+44.4% | 7.17+9.6% | 6.54+17.2% | 5.58-14.2% | 6.50+52.6% | 4.26+1.4% | 4.20 |
| Total Income | 459.48+12.7% | 407.68-9.1% | 448.66+12.7% | 398.11+12.5% | 353.75-6.2% | 377.24-5.9% | 400.73 |
| EXPENSES | |||||||
| Expenditure | 435.54+3.2% | 422.12-3.7% | 438.37+2.8% | 426.51+10.9% | 384.65-1.8% | 391.59+2.1% | 383.35 |
| Tax | 0.27+160.0% | -0.45+91.5% | -5.29-1455.9% | -0.34+92.7% | -4.66-248.9% | 3.13-31.8% | 4.59 |
| PROFIT | |||||||
| PBT | 27.62+235.1% | -20.45-309.5% | 9.76+134.4% | -28.40+8.1% | -30.90-131.3% | -13.36-176.9% | 17.38 |
| Net Profit | 27.35+236.8% | -20.00-232.9% | 15.05+153.6% | -28.06-6.9% | -26.24-156.5% | -10.23-180.0% | 12.79 |
| KEY METRICS | |||||||
| OPM % | 14.85%+9.88pp | 4.97%-6.99pp | 11.96%+8.18pp | 3.78%+2.78pp | 1.00%+16.11pp | -15.11%-8.42pp | -6.69% |
| NPM % | 5.95%+10.86pp | -4.91%-8.26pp | 3.35%+10.40pp | -7.05%+0.37pp | -7.42%-4.71pp | -2.71%-5.90pp | 3.19% |
| EPS | 2.96+36.4% | 2.17+33.1% | 1.63-46.4% | 3.04+6.7% | 2.85+356.8% | -1.11-179.9% | 1.39 |
Corporate Events
Board MeetingINDOCO
202631Mar
Board Meeting
The Board considered and approved the re-appointment of Cost…
BSE Filing ↗ Board MeetingINDOCO
202424Oct
Board Meeting
Consider and approve The Unaudited Standalone and Consolidat…
BSE Filing ↗ Board MeetingINDOCO
202423Jul
Board Meeting
Consider and approve the Unaudited Standalone & Consolidated…
BSE Filing ↗ Board MeetingINDOCO
202416May
Board Meeting
Consider and approve the Audited Standalone and Consolidated…
BSE Filing ↗ Board MeetingINDOCO
202423Jan
Board Meeting
Consider and approve the unaudited standalone and consolidat…
BSE Filing ↗ Board MeetingINDOCO
202319Oct
Board Meeting
consider and approve the unaudited standalone and consolidat…
BSE Filing ↗